Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

NCT05924425 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05924425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05924425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Lead sponsor
University Hospital, Montpellier
Phase
Phase 4
Overall status
Recruiting
Start date
March 13, 2024
Completion date
March 13, 2028
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, insomnia disorder, sleep